The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dominance and delivering strong returns.
Even among industry leaders, some companies shine bright, and we built StockStory to help you find them. That said, here are three Nasdaq 100 stocks that could lead the market.
AMD (AMD)
Market Cap: $405.8 billion
Founded in 1969 by a group of former Fairchild semiconductor executives led by Jerry Sanders, Advanced Micro Devices (NASDAQ: AMD) is one of the leading designers of computer processors and graphics chips used in PCs and data centers.
Why Do We Like AMD?
- Market share has increased this cycle as its 29.9% annual revenue growth over the last five years was exceptional
- Projected revenue growth of 26.4% for the next 12 months is above its two-year trend, pointing to accelerating demand
- Earnings growth has comfortably beaten the peer group average over the last five years as its EPS has compounded at 27.9% annually
At $256.69 per share, AMD trades at 44.7x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free for active Edge members.
Copart (CPRT)
Market Cap: $41.47 billion
Starting as a single salvage yard in California in 1982, Copart (NASDAQ: CPRT) operates an online auction platform that connects sellers of damaged and salvage vehicles with buyers ranging from dismantlers and rebuilders to used car dealers and exporters.
Why Are We Backing CPRT?
- Annual revenue growth of 16.1% over the past five years was outstanding, reflecting market share gains this cycle
- CPRT is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders, and its recently improved profitability means it has even more resources to invest or distribute
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures
Copart is trading at $41.93 per share, or 25.4x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free for active Edge members.
DexCom (DXCM)
Market Cap: $23.86 billion
Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ: DXCM) develops and sells continuous glucose monitoring systems that allow people with diabetes to track their blood sugar levels without repeated finger pricks.
Why Will DXCM Beat the Market?
- Average organic revenue growth of 16.8% over the past two years demonstrates its ability to expand independently without relying on acquisitions
- Earnings per share have massively outperformed its peers over the last five years, increasing by 17.5% annually
- Free cash flow margin increased by 17.5 percentage points over the last five years, giving the company more capital to invest or return to shareholders
DexCom’s stock price of $58.75 implies a valuation ratio of 25.7x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free for active Edge members.
Stocks We Like Even More
Fresh US-China trade tensions just tanked stocks—but strong bank earnings are fueling a sharp rebound. Don’t miss the bounce.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
